Evolving treatment strategies for chronic refractory angina

Bibliography

• MANNHEIMER C, CAMICI P, CHESTER MR et al.: The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur. Heart J. (2002) 23(5):355-370.
   PubMed Web of Science ®Google Scholar
• YANG EH, BARSNESS GW, GERSH BJ, CHANDRASEKARAN K, LERMAN A: Current and future treatment strategies for refractory angina. Mayo Clin. Proc. (2004) 79(10):1284-1292.
   PubMed Web of Science ®Google Scholar
• THADANI U: Current medical management of chronic stable angina. J. Cardiovasc. Pharmacol. Ther. (2004) 9(Suppl. 1):S11-S29.
   PubMedGoogle Scholar
• EGASHIRA K, HIROOKA Y, KUGA T, MOHRI M, TAKESHITA A: Effects of l-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation (1996) 94(2):130-134.
   PubMed Web of Science ®Google Scholar
• CEREMUZYNSKI L, CHAMIEC T, HERBACZYNSKA-CEDRO K: Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris. Am. J. Cardiol. (1997) 80(3):331-333.
   PubMed Web of Science ®Google Scholar
• BOIS P, BESCOND J, RENAUDON B, LENFANT J: Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br. J. Pharmacol. (1996) 118(4):1051-1057.
   PubMed Web of Science ®Google Scholar
• BORER JS, FOX K, JAILLON P, LEREBOURS G, FOR THE IVABRADINE INVESTIGATORS GROUP: Antianginal and antiischemic effects of ivabradine, an if inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation (2003) 107(6):817-823.
   PubMed Web of Science ®Google Scholar
• TARDIF J: INITIATIVE trial. Presented at ESC Congress 2003 Vienna (2003).
   Google Scholar
• BELARDINELLI L, ANTZELEVITCH C, FRASER H: Inhibition of the late sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and it detrimental effects on cardiomyocyte function. Eur. Heart J. (2004) 6(Suppl. 1):13-17.
   Web of Science ®Google Scholar
• SONG Y, SHRYOCK J, WU L, BELARDINELLI L: Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J. Cardiovasc. Pharmacol. (2004) 44:192-199.
   PubMed Web of Science ®Google Scholar
• CHAITMAN BR, SKETTINO SL, PARKER JO et al.: Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J. Am. Coll. Cardiol. (2004) 43(8):1375-1382.
   PubMed Web of Science ®Google Scholar
• CHAITMAN BR, PEPINE CJ, PARKER JO et al.: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA (2004) 291(3):309-316.
   PubMed Web of Science ®Google Scholar
• MARKHAM A, PLOSKER GL, GOA KL: Nicorandil: an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs (2000) 60(4):955-974.
   PubMedGoogle Scholar
• CIAMPRICOTTI R, SCHOTBORGH CE, DE KAM PJ, VAN HERWAARDEN RH: A comparison of nicorandil with isosorbide mononitrate in elderly patients with stable coronary heart disease: the SNAPE study. Am. Heart J. (2000) 139(5):939-943.
   PubMedGoogle Scholar
• DI SOMMA S, LIGUORI V, PETITTO M: A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris. Cardiovasc. Drugs Ther. (1993) 7:119-123.
   PubMedGoogle Scholar
• MEETER K, KELDER JC, TIJSSEN JG et al.: Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study. J. Cardiovasc. Pharmacol. (1992) 20(Suppl. 3):S59-S66.
   Google Scholar
• RAFTERY EB, LAHIRI A, HUGHES LO, ROSE EL: A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. Eur. Heart J. (1993) 14(Suppl. B):35-39.
   PubMedGoogle Scholar
• YAMAZAKI J, IIDA M, IGARASHI M et al.: Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT. Int. J. Clin. Pharmacol. Ther. (1994) 32:183-191.
   PubMedGoogle Scholar
• STANLEY WC, MARZILLI M: Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine. Fundam. Clin. Pharmacol. (2003) 17(2):133-145.
   PubMed Web of Science ®Google Scholar
• MARZILLI M, KLEIN WW: Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis ofrandomized, double-blind, controlled trials. Coron. Artery Dis. (2003) 14(2):171-179.
   PubMed Web of Science ®Google Scholar
• MICHAELS AD, ACCAD M, PORTS TA, GROSSMAN W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation (2002) 106(10):1237-1242.
   PubMed Web of Science ®Google Scholar
• BONETTI PO, BARSNESS GW, KEELAN PC et al.: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J. Am. Coll. Cardiol. (2003) 41(10):1761-1768.
   PubMed Web of Science ®Google Scholar
• KERSTEN JR, PAGEL PS, CHILIAN WM, WARLTIER DC: Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc. Res. (1999) 43(1):44-57.
   PubMedGoogle Scholar
• ARORA RR, CHOU TM, JAIN D et al.: The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J. Am. Coll. Cardiol. (1999) 33(7):1833-1840.
   PubMed Web of Science ®Google Scholar
• ZHENG Z-S, LI T-M, KAMBIC H et al.: Sequential extrenal counterpulsation (SECP) in China. Trans. Am. Soc. Artif. Intern. Organs (1983) 29:599-603.
   PubMedGoogle Scholar
• LAWSON WE, HUI JC, SOROFF HS et al.: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am. J. Cardiol. (1992) 70(9):859-862.
   PubMedGoogle Scholar
• LAWSON WE, HUI JC, ZHENG ZS et al.: Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect? Cardiology (1996) 87(4):271-275.
   PubMedGoogle Scholar
• LAWSON WE, HUI JC, ZHENG SZ et al.: Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am. J. Cardiol (1996) 77(12):1107-1109.
   PubMedGoogle Scholar
• LAWSON WE, HUI JC, GUO T, BURGER L, COHN PF: Prior revascularization increases the effectiveness of enhanced external counterpulsation. Clin. Cardiol. (1998) 21(11):841-844.
   PubMedGoogle Scholar
• LAWSON WE, HUI JC, COHN PF: Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin. Cardiol. (2000) 23(4):254-258.
   PubMedGoogle Scholar
• URANO H, IKEDA H, UENO T et al.: Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J. Am. Coll. Cardiol. (2001) 37(1):93-99.
   PubMed Web of Science ®Google Scholar
• MASUDA D, NOHARA R, HIRAI T et al.: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Evaluation by13N-ammonia positron emission tomography. Eur. Heart J. (2001) 22(16):1451-1458.
   PubMed Web of Science ®Google Scholar
• STYS T, LAWSON WE, HUI JC et al.: Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology (2001) 52(10):653-658.
   PubMedGoogle Scholar
• BARSNESS G, FELDMAN AM, HOLMES DR Jr et al.: The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin. Cardiol. (2001) 24(6):435-442.
   PubMedGoogle Scholar
• STYS TP, LAWSON WE, HUI JC et al.: Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am. J. Cardiol. (2002) 89(7):822-824.
   PubMed Web of Science ®Google Scholar
• GIBBONS RJ, ABRAMS J, CHATTERJEE K et al.: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J. Am. Coll. Cardiol. (2003) 41(1):159-168.
   PubMedGoogle Scholar
• MANNHEIMER C, AUGUSTINSSON LE, CARLSSON CA, MANHEM K, WILHELMSSON C: Epidural spinal electrical stimulation in severe angina pectoris. Br. Heart J. (1988) 59(1):56-61.
   PubMedGoogle Scholar
• ELIASSON T, JERN S, AUGUSTINSSON LE, MANNHEIMER C: Safety aspects of spinal cord stimulation in severe angina pectoris. Coron. Artery Dis. (1994) 5(10):845-850.
   PubMedGoogle Scholar
• JONGSTE MJ, HAAKSMA J, HAUTVAST RW et al.: Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study. Br. Heart J. (1994) 71(5):413-418.
   PubMedGoogle Scholar
• MANNHEIMER C, ELIASSON T, ANDERSSON B et al.: Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. Br. Med. J. (1993) 307(6902):477-480.
   PubMed Web of Science ®Google Scholar
• HAUTVAST RW, BROUWER J, DEJONGSTE MJ, LIE KI: Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chronic intractable angina pectoris – a prospective ambulatory electrocardiographic study. Clin. Cardiol. (1998) 21(1):33-38.
   PubMedGoogle Scholar
• ANDERSEN C, HOLE P, OXHOJ H: Does pain relief with spinal cord stimulation for angina conceal myocardial infarction? Br. Heart J. (1994) 71(5):419-421.
   PubMedGoogle Scholar
• DE JONGSTE MJ, HAUTVAST RW, HILLEGE HL, LIE KI: Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris: a prospective, randomized clinical study. Working Group on Neurocardiology. J. Am. Coll. Cardiol. (1994) 23(7):1592-1597.
   PubMed Web of Science ®Google Scholar
• HAUTVAST RW, DEJONGSTE MJ, STAAL MJ, VAN GILST WH, LIE KI: Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am. Heart J. (1998) 136(6):1114-1120.
   PubMed Web of Science ®Google Scholar
• TENVAARWERK IA, JESSURUN GA, DEJONGSTE MJ et al.: Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. Heart (1999) 82(1):82-88.
   PubMed Web of Science ®Google Scholar
• MANNHEIMER C, ELIASSON T, AUGUSTINSSON L-E et al.: Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation (1998) 97(12):1157-1163.
   PubMed Web of Science ®Google Scholar
• GOLDMAN A, GREENSTONE SM, PREUSS FS, STRAUSS SH, CHANG ES: Experimental methods for producing a collateral circulation to the heart directly from the left ventricle. J. Thorac. Surg. (1956) 31:364-374.
   PubMedGoogle Scholar
• OKADA M, IKUTA H, SHIMIZU K, HORII H, NAKAMURA K: Alternatives method of myocardial revascularization by laser: experimental and clinical study. Kobe J. Med. Sci. (1986) 32(5):151-161.
   PubMedGoogle Scholar
• COOLEY DA, FRAZIER OH, KADIPASAOGLU KA et al.: Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex. Heart Inst. J. (1994) 21(3):220-224.
   PubMedGoogle Scholar
• HARDY RI, BOVE KE, JAMES FW, KAPLAN S, GOLDMAN L: A histologic study of laser-induced transmyocardial channels. Lasers Surg. Med. (1987) 6(6):563-573.
   PubMedGoogle Scholar
• KWONG KF, KANELLOPOULOS GK, NICKOLS JC et al.: Transmyocardial laser treatment denervates canine myocardium. J. Thorac. Cardiovasc. Surg. (1997) 114(6):883-890.
   PubMed Web of Science ®Google Scholar
• ALLEN KB, DOWLING RD, FUDGE TL et al.: Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N. Engl. J. Med. (1999) 341(14):1029-1036.
   PubMed Web of Science ®Google Scholar
• FRAZIER OH, MARCH RJ, HORVATH KA: Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N. Engl. J. Med. (1999) 341(14):1021-1028.
   PubMed Web of Science ®Google Scholar
• SCHOFIELD PM, SHARPLES LD, CAINE N et al.: Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet (1999) 353(9152):519-524.
   PubMed Web of Science ®Google Scholar
• BURKHOFF D, SCHMIDT S, SCHULMAN SP et al.: Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Lancet (1999) 354(9182):885-890.
   PubMed Web of Science ®Google Scholar
• AABERGE L, NORDSTRAND K, DRAGSUND M et al.: Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from The Norwegian Randomized Trial. J. Am. Coll. Cardiol. (2000) 35(5):1170-1177.
   PubMed Web of Science ®Google Scholar
• JONES JW, SCHMIDT SE, RICHMAN BW et al.: Holmium:YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann. Thorac. Surg.(1999) 67(6):1596-1601; discussion 1601-1602.
   PubMed Web of Science ®Google Scholar